15 results about "Skin hyperpigmentation" patented technology

A cosmetic composition comprising: (a) 2-mercaptonicotinoyl glycine; (b) acyl glycinate surfactant; (c) a salt providing divalent cations having a charge density of about 40 to about 200 C / mm3 and a water solubility of at least 400 g / L; (d) anionic polymer; (e) glycerin; (f) water; and (g) reducing agent. The cosmetic composition is particularly useful in a method for brightening skin, depigmenting skin, treating hyperpigmentation of skin, treating melasmic skin, or evening skin tone.

The present disclosure is a peptide (Inpén SEQ ID N ° 1) with whitening action for melasma, a cosmetic or dermopharmaceutic composition containing this peptide as active ingredient and the use of this composition in the treatment of melasma or skin hyperpigmentation, developed from a peptide bioinspired from the venom of Brazilian wasps. Melasma is an acquired chronic dermatologic disorder characterized by the emergence of hyperpigmented skin spots. Although it is a common condition, a definitive cure has not been developed so far, due to the complexity of multifactorial causes. Because it is a cosmetic composition, of topic and painless application, the present disclosure can be applied daily, with no need for a specialist in the field of aesthetics, besides not being expensive as the known to date techniques for treating melasma are. The peptide SEQ ID N° 1 acts inhibiting melanogenesis.

This invention discloses polypeptides or their salts, their preparation methods, and applications, belonging to the field of biotechnology. The polypeptide or its salt according to formula (I) has the following structure: L-methionyl-L-prolyl-D-phenylalanyl-L-arginyl-D-tryptophanyl-L-phenylalanyl-X-L-prolyl-L-valine (I); wherein X is a 4-(aminomethyl)cyclohexane carbonyl group. The polypeptide or its salt of this invention exhibits both antagonistic activity against MC1R receptors and inhibitory activity against tyrosinase, with perfect temporal and spatial synergy, thereby effectively inhibiting melanin production in the skin and improving hyperpigmentation.

A cosmetic composition comprising: (a) 2-mercaptonicotinoyl glycine; (b) acyl glycinate surfactant; (c) a salt providing divalent cations having a charge density of about 40 to about 200 C / mm3 and a water solubility of at least 400 g / L; (d) anionic polymer; (e) glycerin; (f) water; and (g) reducing agent. The cosmetic composition is particularly useful in a method for brightening skin, depigmenting skin, treating hyperpigmentation of skin, treating melasmic skin, or evening skin tone.

The present invention relates to a composition for the prevention and / or treatment of hyperpigmentation of the skin and / or hair, comprising the combination of niacinamide or one of its derivatives with an extract of algae of the genus Cystoseira. The invention also relates to the cosmetic and dermatological uses of the composition according to the invention, as well as a method for preventing and / or treating hyperpigmentation of the skin and / or hair.

Olfactory receptor agonists are presented that exhibit (i) a molecular weight of about 50 to about 300 Daltons and (ii) a relative evaporation rate to butyl acetate of about 3 to about 15 for use as a medicament for the prevention and / or treatment of hyperpigmentation of human skin.

The present invention relates to a cosmetic composition intended for application to the epidermis for the treatment of skin hyperpigmentation by means of a cryogenic fluid and a device configured to ensure the ejection and spraying of a controlled quantity of said fluid, characterized in that it comprises a dose of cryogenic fluid obtained by a sequence of at least one spraying (N) of said fluid onto the epidermis at a flow rate of 0.61 ml / s, in a negative temperature range on the skin of between 0°C and -3°C, creating oscillations of the temperature of said epidermis, the total duration of which is between 1.5 seconds and 25 seconds, each oscillation consisting of a phase of abrupt cooling at a temperature decrease rate of between 50°C / s and 170°C / s followed by a phase of slower increase in temperature up to a temperature of between 20°C and 34°C.

The present invention relates to the use of annexin A5. Specifically, annexin A5 can be used to prepare a composition, the composition being used for (a) preventing and / or treating skin hyperpigmentation; (b) whitening skin; and / or (c) delaying the progression of melanoma. The annexin A5 can significantly inhibit the synthesis of melanin, and inhibit the synthesis of melanin in melanoma cells, and thus has excellent effects of whitening skin and reducing continuous deposition of pigments in melanoma cells.

Provided herein are novel peptides useful in the treatment and / or prevention of skin conditions, such as skin aging, wrinkles, fine lines, sagged skin, hyperpigmented spots and uneven skin tone. Also provided herein are compositions comprising the peptides, and methods and uses involving the peptides and compositions.

A cosmetic composition comprising: (a) ascorbic acid; (b) acyl glycinate surfactant; (c) a salt providing divalent cations having a charge density of about 40 to about 200 C / mm3 and a water solubility of at least 400 g / L; (d) anionic polymer; (e) glycerin; (f) water; and (g) cationic polymer is described. The cosmetic composition is particularly useful in a method for brightening skin, depigmenting skin, treating hyperpigmentation of skin, treating melasmic skin, or evening skin tone.

Digital imaging systems and methods are described for analyzing pixel data of an image of a skin area of a user for determining skin hyperpigmentation. A plurality of training images of a plurality of individuals are aggregated, each of the training images comprising pixel data of a respective skin area of an individual. A skin hyperpigmentation model, trained with the pixel data, is operable to output, across a range of a skin hyperpigmentation scale, skin hyperpigmentation values associated with a degree of skin hyperpigmentation. An image of a user comprising pixel data of at least a portion of a user skin area is received and analyzed, by the skin hyperpigmentation model, to determine a user-specific skin hyperpigmentation value of the user skin area. A user-specific electronic recommendation addressing at least one feature identifiable within the pixel data is generated and rendered, on a display screen of a user computing device.

Compositions for skin creams and serums are provided for treating skin hyperpigmentation, the compositions including cysteamine, tranexamic acid, niacinamide, tetrapeptide 30, DNA repair enzymes, and human growth factors. A formulation for the skin cream or serum includes 5% cysteamine by weight, 5% tranexamic acid by weight, 4% niacinamide by weight, 1% tetrapeptide 30 by weight, in which the tetrapeptide 30 includes the following four amino acids linked together: L-prolyl-L-lysyl-L-alpha-glutamyl-L-lysine. In addition, the cream or serum includes DNA repair enzymes, including 1% phytosomes, 0.3 to 1% roxisomes, and 1% ultrasomes. Further, the composition may include recombinant human growth factors.

The present invention relates to a cosmetic skin lightening composition comprising the combination of sclareolide, kojic acid and ascorbyl glucoside, wherein kojic acid is encapsulated within a targeted microcapsule or nanocapsule having a melanocortin 1 receptor (MC1R) agonist peptide bound to the surface. It was found that such combination of active substances provided synergistic kin-whitening effect. The present invention also relates to the cosmetic use of this composition for skin whitening, particularly, for the elimination or reduction of hyperpigmented marks of the skin, such as UV exposure related marks, post-scar marks, post-inflammation marks, melasma marks, lentigo marks or age-related marks.

A cosmetic composition comprising: (a) 2-mercaptonicotinoyl glycine; (b) acyl glycinate surfactant; (c) a salt providing divalent cations having a charge density of about 40 to about 200 C / mm3 and a water solubility of at least 400 g / L; (d) anionic polymer; (e) glycerin; (f) water; and (g) reducing agent. The cosmetic composition is particularly useful in a method for brightening skin, depigmenting skin, treating hyperpigmentation of skin, treating melasmic skin, or evening skin tone.

Disclosed in the present invention is a use of pyruvate kinase in the preparation of a composition. The composition is used for (a) preventing and / or treating skin hyperpigmentation; (b) skin lightening; and / or (c) delaying the progression of melanoma.